Anupam Rastogi, Managing Partner at Emergent Ventures, discusses his firm’s AI investment thesis.
Podcast: Play in new window | Download
Subscribe: Apple Podcasts | Android | Google Play | Stitcher | TuneIn | RSS
Entrepreneur, Angel Investor, and Board Member Raju Reddy discusses his AI investment thesis.
Podcast: Play in new window | Download
Subscribe: Apple Podcasts | Android | Google Play | Stitcher | TuneIn | RSS
Will you be seeking investor introductions for your startup in 2025?
Top VC funds operate in the 98% rejection rate zone.
Let’s avoid the pitfalls of wasting time and money without achieving results.
If you are looking for investor introductions, you have to be READY.
Please post this on your wall in 2025:
“Startups: Do NOT Go to VCs as Beggars. Go as Kings.”
This is the 1Mby1M mantra and it works.
Over 99% of founders chase funding before they are fundable.
As you know, I categorically support bootstrapped entrepreneurs.
There are numerous startups now that have achieved some revenue without any external funding.
However, it has taken time. Sometimes, it has taken 5-7 years to get there.
VCs, however, are looking for velocity.
Their goal is to achieve $100M in 5-7 years.
Sramana Mitra: What is going on in the thought process of the venture capital community vis-a-vis healthcare drug discovery and general AI in the healthcare and life sciences area? When the lean startup movement came about, SaaS was the dominant field in which VCs were investing for maybe even 15 years, the venture capital industry kind of settled into this model that you bootstrapped to some level of validation and then start raising money.
>>>Sramana Mitra: Some of you here would remember, Gus would definitely remember that many years ago, I came up with a formula for the future of the web. It was called Web 3.0 = (4C + P + VS).
>>>Sramana Mitra: So, Gus, could you also discuss Joanna Strober’s company that you have invested in and have been tracking for a while? I think it’s a good case study to discuss in this context.
Gus Tai: Absolutely. The company is called Midi Health, and I was a seed investor with Midi. That company is a good illustration of how entrepreneurs, regardless of how they want to think about raising money, can approach industries. There was a latent need and a discontinuity in being able to serve that latent need.
>>>